24/7 Wall St. » UTHR

Top Analyst Upgrades & Downgrades (AMZN, AMAT, SAM, CAM, CIM, GNW, MHR, MPEL, NVDA, PKD, PLSX, RF, SVU, UTHR, ZMH)

Administrator — Fri, 11 Nov 2011 13:21:17 +0000

These are some of Friday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls.

Amazon.com Inc. (NASDAQ: AMZN) Started as Neutral at Nomura.
Applied Materials Inc. (NASDAQ: AMAT) Started as Neutral with $13 target at Credit Suisse.
Boston Beer Company (NYSE: SAM) named Momentum stock of the day at Zacks.
Cameron International (NYSE: CAM) Reiterated Buy with $73 target at BofA/ML.
Chimera Investment Corporation (NYSE: CIM) Raised to Neutral at Stern Agee.
Genworth Financial Inc. (NYSE: GNW) Raised to Neutral at Citigroup.
Magnum Hunter Resources (NYSE: MHR) reiterated Buy and raised target to $8.00 at Canaccord Genuity.
Melco Crown Entertainment Ltd. (NASDAQ: MPEL) maintained Neutral but cut target to $14 at JPMorgan.
NVIDIA Corporation (NASDAQ: NVDA) Reiterated Buy with $18 target at BofA/ML.
Parker Drilling Company (NYSE: PKD) named value stock of the day at Zacks.
Plexus Corporation (NASDAQ: PLXS) named Bear of the Day at Zacks.
Regions Financial Corporation (NYSE: RF) Started as Outperform at BMO Capital.
SUPERVALU Inc. (NYSE: SVU) Reinstated as Neutral at BofA/ML.
United Therapeutics (NASDAQ: UTHR) Raised to Outperform as Bull of the Day as Zacks.
Zimmer Holdings Inc. (NYSE: ZMH) Cut to Hold at Argus.

JON C. OGG

Filed under: Analyst Calls Tagged: AMAT, AMZN, CAM, CIM, GNW, MHR, MPEL, NVDA, PKD, PLSX, RF, SAM, SVU, UTHR, ZMH

Top Active Trader Alert Stocks (ELN, S, UTHR)

247wallst — Wed, 24 Aug 2011 12:52:24 +0000

Active traders and day traders have many stocks to choose from this Wednesday morning. We are tracking news and moves in shares of Elan Corporation, plc. (NYSE: ELN), Sprint Nextel Corporation (NYSE: S), United Therapeutics Corporation (NASDAQ: UTHR).

Elan Corporation, plc. (NYSE: ELN) is up 5.6% premarket to $10.17, relative to a 52-week range of $4.25-$12.60. The company was upgraded from neutral to outperform at Credit Suisse, and is being buoyed by gains in the UK markets.

Sprint Nextel Corporation (NYSE: S) is up 1.6% premarket to $3.65, within a 52-week range of $2.98-$6.45. There are rumors that the carrier will provide coverage for the iPhone 5.

United Therapeutics Corporation (NASDAQ: UTHR) is down 19% premarket to $39.45, relative to a 52-week range of $46.14-$70.74. The company was downgraded to hold from buy at Deutsche Bank.

Filed under: General Tagged: ELN, S, UTHR

Top Active Trader Alert Stocks (BPAX, STKL, UTHR)

247wallst — Mon, 06 Jun 2011 12:52:23 +0000

Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves in shares of BioSante Pharmaceuticals (NASDAQ: BPAX), unOpta, Inc. (NASDAQ: STKL), and United Therapeutics Corporation (NASDAQ: UTHR).

BioSante Pharmaceuticals (NASDAQ: BPAX) is up 4% before market open to $3.12, relative to a 52-week range of $1.29-$3.20. The FDA recently lifted a clinical hold it had placed on the company’s prostate cancer vaccine.

SunOpta, Inc. (NASDAQ: STKL) is up 17.5% premarket to $8.70, relative to a 52-week range of $3.98-$8.83. Shares are up after Jim Cramer spoke favorable of the stock on his “Mad Money” TV show.

United Therapeutics Corporation (NASDAQ: UTHR) is down roughly 6% premarket to $58.90, relative to a 52-week range of $46.14-$70.74. The company announced the primary endpoint of a hypertension drug it had been performing trials on.

Filed under: Pre-Market Activity, Trading Alert Tagged: BPAX, SKTL, UTHR

M&A Watch: Biotech Deals Keep Rolling, Who Is The Next Buyout Target? (TEVA, VRX, CEPH, CRA, ALXN, DNDN, CBST, HGSI, UTHR, CADX, AMAG, SGMO)

Administrator — Mon, 02 May 2011 23:46:51 +0000

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) has trumped Valeant Pharmaceuticals International, Inc. (NYSE: VRX) after it agreed to acquire Cephalon Inc. (NASDAQ: CEPH) in a $6.8 billion deal. The merger will give the mostly-generic Teva a portfolio of candidates in biotech drugs targeting cancer, pain, inflammatory diseases and more.

Teva’s $81.50 offer per share in cash may seem like a low premium of only about 6% to the closing price on Friday, but this is about 12% higher than Cephalon’s earlier $73 per share offer. More importantly, this is nearly a 40% premium to Cephalon’s pre-merger offers. The boards of directors of Teva and Cephalon have each voted in favor of this merger. What we are most curious about is simple… Which biotech and small pharmaceutical companies will be next to be acquired?

Celera Corporation (NASDAQ: CRA) is one we felt made sense for genomics, particularly when you consider that so much of Celera was raw cash. At that time of the deal, we also updated several other genomic possible targets.

Cephalon was noted as a possible buyout target even back at the end of January, and we gave a list with explanations on each of the following and more: Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN); Dendreon Corporation (NASDAQ: DNDN); Human Genome Sciences, Inc. (NASDAQ: HGSI); Cubist Pharmaceuticals Inc. (NASDAQ: CBST); United Therapeutics Corporation (NASDAQ: UTHR); Cadence Pharmaceuticals Inc. (NASDAQ: CADX); AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG); and Sangamo Biosciences Inc. (NASDAQ: SGMO). Details with explanations on that full list here.

Foreign buyers have an advantage of preying on US companies due to the incredibly weak U.S. Dollar and drug companies are looking to bolster sagging drug pipelines. The deals will continue, but the real risk for biotech investors is that there will be very few quality companies with real earnings left to invest in.

Not all of these other companies will be acquired. Some are too expensive though others offer a buyer a significant pipeline and emerging drug boost… for those willing to pay up.

JON C. OGG

Filed under: Biotech, Drug companies, Mergers and Buy Outs, Pharmaceuticals, Rumors Tagged: ALXN, ANAG, CADX, CBST, CEPH, CRA, DNDN, HGSI, SGMO, TEVA, UTHR, VRX

Top Analyst Upgrades & Downgrades (ALTR, MT, ADM, BRCM, HOC, JBLU, MD, NVTL, ORCL, RIMM, SAI, SUP, UTHR)

Administrator — Fri, 25 Mar 2011 12:30:51 +0000

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning.

Altera Corporation (NASDAQ: ALTR) Raised to Buy at Citigroup.
ArcelorMittal (NYSE: MT) Started as Outperform at RBC.
Archer Daniels Midland Company (NYSE: ADM) Cut to Market Perform at BMO.
Broadcom Corporation (NASDAQ: Maintained Buy at Argus.
Holly Corp. (NYSE: HOC) Raised to Buy at BofA/ML.
Jetblue Airways Corporation (NASDAQ: JBLU) Raised to Buy at Soleil.
Mednax Inc. (NYSE: MD) Raised to Buy at BofA/ML.
Novatel Wireless, Inc. (NASDAQ: NVTL) Maintained Underperform as Bear of the Day at Zacks.
Oracle Corporation (NASDAQ: ORCL) Reiterated Outperform asd #1 Pick at Credit Suisse.
Research in Motion Ltd. (NASDAQ: RIMM) Cut to Neutral at BofA/ML; Maintained Outperform at Credit Suisse.
SAIC Inc. (NYSE: SAI) Cut to Neutral at Credit Suisse.
Superior Industries International, Inc. (NYSE: SUP) Maintained as Outperform and Bull of the Day at Zacks.
United Therapeutics Corporation (NASDAQ: UTHR) Started as Buy at Deutsche Bank.

You can join our free daily email distribution list to hear more about analyst upgrades and downgrades, top day trader and active trader alerts, dividend trends, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Filed under: Analyst Calls Tagged: ADM, ALTR, BRCM, HOC, JBLU, MD, MT, NVTL, ORCL, RIMM, SAI, SUP, UTHR

Top Analyst Upgrades and Downgrades (AEG, BHI, BP, K, KKD, MBT, NAV, CRM, SLB, UTHR, VIP, WFT)

Administrator — Thu, 10 Jun 2010 12:27:16 +0000

These are some of the top analyst upgrades, downgrades and initiations we have seen from Wall Street research calls this Thursday morning:

AEGON NV (NYSE: AEG) Cut to Market Perform at KBW.
Baker Hughes Inc. (NYSE: BHI) Raised to Overweight at JPMorgan.
BP plc (NYSE: BP) Cut to Hold at S&P Equity Research; targets cut by Citi.
Kellogg Company (NYSE: K) Started as Buy at Cantor Fitzgerald.
Krispy Kreme Doughnuts (NYSE: KKD) Started as Buy with $6.00 target at Roth Capital.
Mobile Telesystems (NYSE: MBT) Raised to Neutral at Credit Suisse.
Navistar International (NYSE: NAV) Raised to Buy at UBS.
Salesforce.com Inc. (NYSE: CRM) Started as Outperform at Morgan Keegan.
Schlumberger Ltd. (NYSE: SLB) Raised to Strong Buy at S&P Equity Research (late yesterday call).
United Therapeutics (NASDAQ: UTHR) Raised to Overweight at JPMorgan.
VimpelCom (NYSE: VIP) Started as Outperform at Credit Suisse.
Weatherford International Ltd. (NYSE: WFT) Raised to Neutral at JPMorgan.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Sponsor: 3 Recovery Stocks to Own Now – Get the names of the best cheap stocks to rebuild your wealth in 2010 and beyond.

Filed under: Analyst Calls Tagged: AEG, BHI, BP, CRM, K, KKD, MBT, NAV, SLB, UTHR, VIP, WFT

Top 10 Analyst Upgrades and Downgrades (AGN, BKC, BEN, GPS, GENZ, HURN, MMM, SSS, WEN, UTHR)

247wallst — Mon, 03 Aug 2009 11:43:59 +0000

These are the top ten analyst upgrades and downgrades we have seen from Wall Street firms early this Monday morning:

Allergan (AGN) Raised to Outperform at Baird.
Burger King (BKC) Cut to Neutral at JP Morgan.
Franklin Resources (BEN) Raised to Buy at Goldman Sachs.
Gap (GPS) Raised to Overweight at Barclays.
Genzyme (GENZ) Cut to Neutral at UBS.
Huron (HURN) Cut to Hold at Deutsche Bank; Cut to Underperform at Oppenheimer; Cut to Underperform at Baird.
3M (MMM) Raised to Buy at Goldman Sachs.
Sovran Self Storage (SSS) Cut to Underperform at Oppenheimer.
Wendy’s (WEN) Raised to Buy at UBS.
United Therapeutics (UTHR) Cut to Hold at Jefferies.

Jon C. Ogg
August 3, 2009

Posted in Analyst Calls Tagged: AGN, BEN, BKC, GENZ, GPS, HURN, MMM, SSS, UTHR, WEN

Top Analyst Upgrades (ANF, AEP, BUCY, EXR, IFX, JOYG, LPL, TWX, UTHR, WYNN)

247wallst — Mon, 06 Apr 2009 12:40:29 +0000

These are some of the top pre-market analyst upgrades and positive research calls we have seen from all Street this Monday morning:

Abercrombie & Fitch (ANF) Started as Buy at Brean Murray.
American Electric (AEP) Raised to Buy at KeyBanc Capital.
Bucyrus (BUCY) Raised to Neutral at JPMorgan.
Extra Space Storage (EXR) Raised to Buy at Citigroup.
Infineon (IFX) Raised to Buy at UBS.
Joy Global (JOYG) Raised to Neutral at JPMorgan.
LG Display (LPL) Started as Buy at Collins Stewart.
Time Warner Cable (TWC) Raised to Buy at Collins Stewart.
United Therapeutics (UTHR) Started as Buy at Lazard Capital Markets.
Wynn Resorts (WYNN) Raised to Buy at UBS.

JON C. OGG

Posted in Analyst Calls Tagged: AEP, ANF, BUCY, EXR, IFX, JOYG, LPL, TWX, UTHR, WYNN

Top 10 Early Bird Analyst Upgrades & Downgrades (COGT, PSUN, RMD, NCTY, SAFM, UTHR, ARB, CS, CTRP, SUN)

247wallst — Wed, 19 Nov 2008 07:11:25 +0000

These are ten of the early bird analyst upgrades and downgrades we are seeing from Wall Street this Wednesday morning:

Cogent Inc. (COGT) Raised to Overweight at JPMorgan.
Pacific Sunwear (PSUN) Raised to Neutral from Sell at UBS.
ResMed (RMD) Started as Buy at Jefferies.
The9 Ltd. (NCTY) Raised to Hold from Sell at Citigroup.
Sanderson Farms (SAFM) Raised to neutral from Underweight at JPMorgan.
United Therapeutics (UTHR) Raised to Neutral from Sell at Piper Jaffray.
Arbitron (ARB) Cut to Neutral at JPMorgan.
Credit Suisse (CS) Cut to Sell from Neutral at UBS.
CTrip.com (CTRP) Cut to Sell from Buy at Citigroup; price target cut to $30.40 at Credit Suisse.
Sunoco (SUN) Cut to Sell from Hold at Deutsche Bank.

Jon C. Ogg
November 19, 2008

Posted in Analyst Calls Tagged: ARB, COGT, CS, CTRP, NCTY, PSUN, RMD, SAFM, SUN, UTHR

The 52-Week Low Club (BIDU)(CAR)(MRT)(UTHR)

247wallst — Mon, 17 Nov 2008 15:58:41 +0000

Baidu (BIDU) Looks like a little run-in with the Chinese government. Down to $130.51 from 52-week high of $418.22.

Avis Budget (CAR) Downgraded by Barclays on debt concerns. Off to $.88 from 52-week high of $18.

MetLife (MET) Concerns about capital crisis spreading to insurance companies. Hits $22.48 down from 52-week high of $67.21.

United Therapeutics (UTHR) Disappointing drug trial. Falls to $56.29 from 52-week high of $117.82.

Douglas A. McIntyre

Posted in HI/LOW Tagged: BIDU, CAR, MET, UTHR